MicroRNA regulation of lipoprotein metabolism

Current Opinion in Lipidology

Volumn 25, Issue 4, 2014, Pages 282-288

  Goedeke, Leigh ^a,b   Aranda, Juan F ^a   Fernández Hernando, Carlos ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

cholesterol homeostasis; lipoprotein metabolism; miRNAs

Indexed keywords

ABC TRANSPORTER A1; ABC TRANSPORTER G1; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MICRORNA; MICRORNA 122; MICRORNA 144; MICRORNA 182; MICRORNA 183; MICRORNA 185; MICRORNA 30C; MICRORNA 33A; MICRORNA 33B; MICRORNA 96; SCAVENGER RECEPTOR BI; UNCLASSIFIED DRUG;

CHOLESTEROL BLOOD LEVEL; GENE LOCUS; HOMEOSTASIS; HUMAN; LIPOPROTEIN METABOLISM; LIPOPROTEIN SECRETION; NONHUMAN; PRIORITY JOURNAL; PROTEIN TARGETING; REVIEW;

EID: 84904187248     PISSN: 09579672     EISSN: 14736535     Source Type: Journal    
DOI: 10.1097/MOL.0000000000000094     Document Type: Review

References (49)

1. Fernandez-Hernando C, Ramirez CM, Goedeke L, Suarez Y. MicroRNAs in metabolic disease. Arterioscler Thromb Vasc Biol 2013; 33:178-185.
2. Fernandez-Hernando C, Suarez Y, Rayner KJ, Moore KJ. MicroRNAs in lipid metabolism. Curr Opin Lipidol 2011; 22:86-92.
3. Moore KJ, Rayner KJ, Suarez Y, Fernandez-Hernando C. MicroRNAs and cholesterol metabolism. Trends Endocrinol Metab 2010; 21:699-706.
4. Ambros V. The functions of animal microRNAs. Nature 2004; 431:350-355.
5. Bartel DP. MicroRNAs: Genomics, biogenesis, mechanism, and function. Cell 2004; 116:281-297.
6. Bartel DP. MicroRNAs: Target recognition and regulatory functions. Cell 2009; 136:215-233.
7. Filipowicz W, Bhattacharyya SN, Sonenberg N. Mechanisms of posttranscriptional regulation by microRNAs: Are the answers in sight? Nat Rev Genet 2008; 9:102-114.
8. Elmen J, Lindow M, Schutz S, et al. LNA-mediated microRNA silencing in nonhuman primates. Nature 2008; 452:896-899.
9. Esau C, Davis S, Murray SF, et al. miR-122 regulation of lipid metabolism revealed by in vivo antisense targeting. Cell Metab 2006; 3:87-98.
10. Soh J, Iqbal J, Queiroz J, et al. MicroRNA-30c reduces hyperlipidemia and atherosclerosis in mice by decreasing lipid synthesis and lipoprotein secretion. Nat Med 2013; 19:892-900.
11. Jeon TI, Esquejo RM, Roqueta-Rivera M, et al. An SREBP-responsive micro-RNA operon contributes to a regulatory loop for intracellular lipid homeostasis. Cell Metab 2013; 18:51-61.
12. Yang M, Liu W, Pellicane C, et al. Identification of miR-185 as a regulator of de novo cholesterol biosynthesis and low density lipoprotein uptake. J Lipid Res 2014; 55:226-238.
13. de Aguiar Vallim T, Tarling E, Kim T, et al. MicroRNA-144 regulates hepatic ABCA1 and plasma HDL following activation of the nuclear receptor FXR. Circ Res 2013; 112:1602-1612.
14. Marquart TJ, Allen RM, Ory DS, Baldan A. miR-33 links SREBP-2 induction to repression of sterol transporters. Proc Natl Acad Sci USA 2010; 107:12228-12232.
15. Najafi-Shoushtari SH, Kristo F, Li Y, et al. MicroRNA-33 and the SREBP host genes cooperate to control cholesterol homeostasis. Science 2010; 328:1566-1569.
16. Ramirez CM, Rotllan N, Vlassov AV, et al. Control of cholesterol metabolism and plasma HDL levels by miRNA-144. Circ Res 2013; 112:1592-1601.
17. Rayner KJ, Suarez Y, Davalos A, et al. MiR-33 contributes to the regulation of cholesterol homeostasis. Science 2010; 328:1570-1573.
18. Elmen J, Lindow M, Silahtaroglu A, et al. Antagonism of microRNA-122 in mice by systemically administered LNA-antimiR leads to up-regulation of a large set of predicted target mRNAs in the liver. Nucleic Acids Res 2008; 36:1153-1162.
19. Krutzfeldt J, Rajewsky N, Braich R, et al. Silencing of microRNAs in vivo with 'antagomirs'. Nature 2005; 438:685-689.
20. Brown MS, Goldstein JL. The SREBP pathway: Regulation of cholesterol metabolism by proteolysis of a membrane-bound transcription factor. Cell 1997; 89:331-340.
21. Horton JD, Goldstein JL, Brown MS. SREBPs: Activators of the complete program of cholesterol and fatty acid synthesis in the liver. J Clin Invest 2002; 109:1125-1131.
22. Brown MS, Goldstein JL. Familial hypercholesterolemia: Defective binding of lipoproteins to cultured fibroblasts associated with impaired regulation of 3-hydroxy-3-methylglutaryl coenzyme A reductase activity. Proc Natl Acad Sci USA 1974; 71:788-792.
23. Brown MS, Goldstein JL. A receptor-mediated pathway for cholesterol homeostasis. Science 1986; 232:34-47.
24. Yabe D, Brown MS, Goldstein JL. Insig-2, a second endoplasmic reticulum protein that binds SCAP and blocks export of sterol regulatory elementbinding proteins. Proc Natl Acad Sci USA 2002; 99:12753-12758.
25. Yang T, Espenshade PJ, Wright ME, et al. Crucial step in cholesterol homeostasis: Sterols promote binding of SCAP to INSIG-1, a membrane protein that facilitates retention of SREBPs in ER. Cell 2002; 110:489-500.
26. Bengoechea-Alonso MT, Ericsson J. A phosphorylation cascade controls the degradation of active SREBP1. J Biol Chem 2009; 284:5885-5895.
27. Abifadel M, Varret M, Rabes JP, et al. Mutations in PCSK9 cause autosomal dominant hypercholesterolemia. Nat Genet 2003; 34:154-156.
28. Maxwell KN, Breslow JL. Adenoviral-mediated expression of Pcsk9 in mice results in a low-density lipoprotein receptor knockout phenotype. Proc Natl Acad Sci USA 2004; 101:7100-7105.
29. Zelcer N, Hong C, Boyadjian R, Tontonoz P. LXR regulates cholesterol uptake through Idol-dependent ubiquitination of the LDL receptor. Science 2009; 325:100-104.
30. Tontonoz P. Transcriptional and posttranscriptional control of cholesterol homeostasis by liver X receptors. Cold Spring Harb Symp Quant Biol 2011; 76:129-137.
31. Bodzioch M, Orso E, Klucken J, et al. The gene encoding ATP-binding cassette transporter 1 is mutated in Tangier disease. Nat Genet 1999; 22:347-351.
32. Brooks-Wilson A, Marcil M, Clee SM, et al. Mutations in ABC1 in Tangier disease and familial high-density lipoprotein deficiency. Nat Genet 1999; 22:336-345.
33. Rust S, RosierM, Funke H, et al. Tangier disease is caused by mutations in the gene encoding ATP-binding cassette transporter 1. Nat Genet 1999; 22:352-355.
34. Adlakha YK, Khanna S, Singh R, et al. Pro-apoptotic miRNA-128-2 modulates ABCA1, ABCG1 and RXRa expression and cholesterol homeostasis. Cell Death Dis 2013; 4:e780.
35. Goedeke L, Vales-Lara FM, Fenstermaker M, et al. A regulatory role for microRNA 33-in controlling lipid metabolism gene expression. Mol Cell Biol 2013; 33:2339-2352.
36. Kang MH, Zhang LH, Wijesekara N, et al. Regulation of ABCA1 protein expression and function in hepatic and pancreatic islet cells by miR-145. Arterioscler Thromb Vasc Biol 2013; 33:2724-2732.
37. Kim J, Yoon H, Ramirez CM, et al. MiR-106b impairs cholesterol efflux and increases Ab levels by repressing ABCA1 expression. Exp Neurol 2012; 235:476-483.
38. Ramirez CM, Davalos A, Goedeke L, et al. MicroRNA-758 regulates cholesterol efflux through posttranscriptional repression of ATP-binding cassette transporter A1. Arterioscler Thromb Vasc Biol 2011; 31:2707-2714.
39. Shirasaki T, Honda M, Shimakami T, et al. MicroRNA-27a regulates lipid metabolism and inhibits hepatitis C virus replication in human hepatoma cells. J Virol 2013; 87:5270-5286.
40. Wang D, Xia M, Yan X, et al. Gut microbiota metabolism of anthocyanin promotes reverse cholesterol transport in mice via repressing miRNA-10b. Circ Res 2012; 111:967-981.
41. Rayner KJ, Esau CC, Hussain FN, et al. Inhibition of miR-33a/b in nonhuman primates raises plasma HDL and lowers VLDL triglycerides. Nature 2011; 478:404-407.
42. Rottiers V, Obad S, Petri A, et al. Pharmacological inhibition of a microRNA family in nonhuman primates by a seed-targeting 8-mer antimiR. Sci Transl Med 2013; 5:212-162.
43. Horie T, Ono K, Horiguchi M, et al. MicroRNA-33 encoded by an intron of sterol regulatory element-binding protein 2 (Srebp2) regulates HDL in vivo. Proc Natl Acad Sci USA 2010; 107:17321-17326.
44. Horie T, Nishino T, Baba O, et al. MicroRNA-33 regulates sterol regulatory element-binding protein 1 expression in mice. Nat Commun 2013; 4:2883.
45. Miller AM, Gilchrist DS, Nijjar J, et al. MiR-155 has a protective role in the development of non-alcoholic hepatosteatosis in mice. PloS One 2013; 8:e72324.
46. Zhong D, Huang G, Zhang Y, et al. MicroRNA-1 and microRNA-206 suppress LXRa-induced lipogenesis in hepatocytes. Cellular Signalling 2013; 25:1429-1437.
47. Sun D, Zhang J, Xie J, et al. MiR-26 controls LXR-dependent cholesterol efflux by targeting ABCA1 and ARL7. FEBS Lett 2012; 586:1472-1479.
48. Hu Z, Shen WJ, Kraemer FB, Azhar S. MicroRNAs 125a and 455 repress lipoprotein-supported steroidogenesis by targeting scavenger receptor class B type I in steroidogenic cells. Mol Cell Biol 2012; 32:5035-5045.
49. Wang L, Jia XJ, Jiang HJ, et al. MicroRNAs 185, 96, and 223 repress selective high-density lipoprotein cholesterol uptake through posttranscriptional inhibition. Mol Cell Biol 2013; 33:1956-1964.